Form D · Biotechnology
Endosphere, Inc.
Columbus, OH · CIK 0001509416
Offering snapshot reported Jun 18, 2015 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $1.56K Reported outside-investor minimum
- First sale
- May 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2015 | Initial | $2,000,000 | No comparison | 17 | SEC filing |
| Apr 26, 2012 | Initial | $3,148,584 | No comparison | 31 | SEC filing |
| Jan 10, 2011 | Initial | $1,305,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242106
Source: Form D, filed Jun 18, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Huston | Director |
| John R Lyon | Director |
| James Mc Kinley | Director, Executive |
| Patrick O'donnell | Director, Executive |
| Ajit Thakur | Director |
| Christopher Thorne | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4449 Easton Way, 2nd Floor
Columbus, OH, 43219
Columbus, OH, 43219